Edit
Shantani Proteome Analytics Pvt. Ltd.
http://www.shantani.com/Last activity: 17.07.2012
Active
Shantani Proteome Analytics Pvt. Ltd. is a solution provider and offers its services in both Target Identification Technologies and Biopharmaceutical characterization services.
Target Identification Technologies: Shantani’s portfolio of services, based on advanced chemical proteomics technologies, helps in identifying and validating drug targets of small molecules. It allows early de-risking of drug-discovery programs and supports crucial Go/No-Go decisions throughout the drug discovery process. Based on the discovery program’s need, we offer several Target ID technologies. Proprietary Technologies-
Unique Polymer Technology (UPT™)
Sub-Cellular Location Specific (SCLS™)
Computational Supreme (COMP-S™)
Generic Technologies-
Traditional Bead and Biotinylation (TBB)
Photo-affinity Labelling (PAL)
Biopharmaceutical Characterization Services: We provide rapid and path forwarding solutions to complex bioanalytical and biopharma product development problems. Shantani’s professional team of experts has more than a decade of experience in high-resolution mass spectrometry, optical spectroscopy, cell biology, biopharmaceutical production and QC/Regulatory processes. Our consultative approach, availability of high-end instrumentation and utilization of cutting-edge technologies help us provide high-quality data at rapid turnaround time.
Our Expertise:
· Intact Mass Analysis
· Peptide Mapping
· Amino Acid Composition Analysis
· N-Terminal Sequencing
· Circular Dichroism
· Disulphide Bond Analysis
· Fourier Transform Infrared Spectroscopy
· Structural assessment using Fluorescence
· Charge variant analysis
· Free Thiol Assays
· Oxidation/Deamidation Analysis
· Impurity profiling by SEC/IEF/HIC/WCX
· Carbohydrate Mapping /Glycan Profiling
Target Identification Technologies: Shantani’s portfolio of services, based on advanced chemical proteomics technologies, helps in identifying and validating drug targets of small molecules. It allows early de-risking of drug-discovery programs and supports crucial Go/No-Go decisions throughout the drug discovery process. Based on the discovery program’s need, we offer several Target ID technologies. Proprietary Technologies-
Unique Polymer Technology (UPT™)
Sub-Cellular Location Specific (SCLS™)
Computational Supreme (COMP-S™)
Generic Technologies-
Traditional Bead and Biotinylation (TBB)
Photo-affinity Labelling (PAL)
Biopharmaceutical Characterization Services: We provide rapid and path forwarding solutions to complex bioanalytical and biopharma product development problems. Shantani’s professional team of experts has more than a decade of experience in high-resolution mass spectrometry, optical spectroscopy, cell biology, biopharmaceutical production and QC/Regulatory processes. Our consultative approach, availability of high-end instrumentation and utilization of cutting-edge technologies help us provide high-quality data at rapid turnaround time.
Our Expertise:
· Intact Mass Analysis
· Peptide Mapping
· Amino Acid Composition Analysis
· N-Terminal Sequencing
· Circular Dichroism
· Disulphide Bond Analysis
· Fourier Transform Infrared Spectroscopy
· Structural assessment using Fluorescence
· Charge variant analysis
· Free Thiol Assays
· Oxidation/Deamidation Analysis
· Impurity profiling by SEC/IEF/HIC/WCX
· Carbohydrate Mapping /Glycan Profiling
Location: India, Maharashtra, Pune
Employees: 11-50
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Blume Vent... | blume.vc |
Mentions in press and media 1
| Date | Title | Description |
| 17.07.2012 | India Innovation Fund, Blume Ventures invest in Shantani Proteome Analytics | India Innovation Fund, which focuses on early-stage investments, has invested an undisclosed amount in Pune-based Shantani Proteome Analytics Pvt Ltd, along with Blume Ventures. Founded in 2010, Shantani is a biotechnology company, which de... |